Stay updated on Pembrolizumab Combo in Resectable NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The timeline for the modernization of the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.
    Difference
    0.4%
    Check dated 2025-06-19T05:23:34.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-11T21:06:49.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    0.6%
    Check dated 2025-05-28T13:47:20.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-30T00:16:03.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page has been updated to include new identifiers and drug names related to a clinical trial for non-small cell lung cancer, while significant details about the trial's design and criteria have been removed.
    Difference
    12%
    Check dated 2025-04-22T18:03:24.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-08T09:29:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Resectable NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page.